# To Evaluate add-on Effect of Nisha-Amalaki Tablets Along With Insulin on Glycemic Control in Type 1 Diabetes Patients (RCTNA)

> **NCT06487598** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Hirabai Cowasji Jehangir Medical Research Institute** · enrollment: 70 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** inj insulin to one group
- **DRUG:** Inj Insulin with Tab Nisha-Amalaki 500 mg twice a day

## Key facts

- **NCT ID:** NCT06487598
- **Lead sponsor:** Hirabai Cowasji Jehangir Medical Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-07-01
- **Primary completion:** 2025-07
- **Final completion:** 2025-07
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2024-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06487598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06487598, "To Evaluate add-on Effect of Nisha-Amalaki Tablets Along With Insulin on Glycemic Control in Type 1 Diabetes Patients (RCTNA)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06487598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*